Evidence map›Paper›PMID 38539718›Full record

ArticleEntropy (Basel, Switzerland)2024

Research on Risk Contagion in ESG Industries: An Information Entropy-Based Network Approach.

Chenglong Hu, Ranran Guo

Open access · goldAbstract read
In one paragraph

Article in Entropy (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
11.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Chenglong HuDepartment of Statistics and Finance, School of Management, University of Science and Technology of China, Hefei 230026, China.
Ranran GuoDepartment of Statistics and Finance, School of Management, University of Science and Technology of China, Hefei 230026, China.
University of Science and Technology of China · CN

Funding

National Natural Science Foundation of China 71903154
6 · The paper itself

Abstract

Sustainable development is a practical path to optimize industrial structures and enhance investment efficiency. Investigating risk contagion within ESG industries is a crucial step towards reducing systemic risks and fostering the green evolution of the economy. This research constructs ESG industry indices, taking into account the possibility of extreme tail risks, and employs VaR and CoVaR as measures of tail risk. The TENET network approach is integrated to to capture the structural evolution and direction of information flow among ESG industries, employing information entropy to quantify the topological characteristics of the network model, exploring the risk transmission paths and evolution patterns of ESG industries in an extreme tail risk event. Finally, Mantel tests are conducted to examine the existence of significant risk spillover effects between ESG and traditional industries. The research finds strong correlations among ESG industry indices during stock market crash, Sino-US trade frictions, and the COVID-19 pandemic, with industries such as the COAL, CMP, COM, RT, and RE playing key roles in risk transmission within the network, transmitting risks to other industries. Affected by systemic risk, the information entropy of the TENET network significantly decreases, reducing market information uncertainty and leading market participants to adopt more uniform investment strategies, thus diminishing the diversity of market behaviors. ESG industries show resilience in the face of extreme risks, demonstrating a lack of significant risk contagion with traditional industries.

Indexed as

ESGinformation entropyrisk contagiontail risk network

Identifiers

PMID38539718
PMCPMC10969389
OpenAlexW4392190111

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.